Immune-inflammatory proteomics associated with elevated cardiovascular risk in genetically determined familial hypercholesterolemia
Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK biobank
Universal screening is an effective strategy for detecting patients with familial hypercholesterolemia
Is the risk of atherosclerotic cardiovascular disease different between genotype determined or measured LP(a) levels?